edetic acid has been researched along with Arteriosclerosis, Coronary in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Dans, AL; Forster, R; Sulit, DV; Tan, FN; Villarruz-Sulit, MV | 1 |
| Jahangir, A; Mookadam, F; Murarka, S; Sultan, S; Tajik, AJ | 1 |
| Danikiewicz, A; Gąsior, M; Hudzik, B; Korzonek-Szlacheta, I; Lekston, A; Nowak, J; Szkodziński, J; Zubelewicz-Szkodzińska, B | 1 |
| Einecke, D | 1 |
| Brennan, P; Johansson, M; Midttun, O; Nygård, O; Townsend, MK; Tworoger, SS; Ueland, PM | 1 |
| Antonov, SA; Nedevska, MT; Stoinova, VV; Trendafilov, II; Vazelov, ES; Yonova, DH | 1 |
| Anstrom, KJ; Boineau, R; Clapp-Channing, NE; Drisko, J; Goertz, C; Knight, JD; Lamas, GA; Lee, KL; Liu, DM; Mark, DB; Nahin, RL; Rosenberg, Y; Rozema, TC | 1 |
| Atwood, KC; Baratz, RS; Sampson, WI; Woeckner, E | 1 |
| Mitka, M | 1 |
| Boineau, R; Drisko, JA; Goertz, C; Lamas, GA; Lee, KL; Mark, DB; Nahin, RL; Rozema, T | 1 |
| Ghali, WA; King-Shier, KM; Knutson, ML; Mather, C; Quan, H; Verhoef, MJ | 1 |
| Ernst, E | 1 |
| Anderson, TJ; Hubacek, J; Knudtson, ML; Wyse, DG | 1 |
| AYTAN, N; KITCHELL, JR; MELTZER, LE; PALMON, F | 1 |
| BASSETT, DR; ROSENBLATT, G; STOKES, J | 1 |
| Kilinc, E; Kultursay, H; Sagcan, A; Yalcin, A | 1 |
| Babu, AN; Gonzalez-Pena, H | 1 |
| Green, DJ; Maiorana, A; O'Driscoll, JG; Scrimgeour, NB; Taylor, RR; Weerasooriya, R | 1 |
| Nissel, H | 1 |
2 review(s) available for edetic acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Chelation therapy for atherosclerotic cardiovascular disease.
Topics: Angina Pectoris; Arteriosclerosis; Cause of Death; Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Stroke | 2020 |
Chelation therapy in cardiovascular disease: an update.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Myocardial Infarction; Off-Label Use; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
4 trial(s) available for edetic acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Most blood biomarkers related to vitamin status, one-carbon metabolism, and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovas
Topics: Adult; Aged; Biomarkers; Blood Specimen Collection; Carbon; Chemistry, Clinical; Coronary Artery Disease; Double-Blind Method; Edetic Acid; Female; Heparin; Humans; Kynurenine; Male; Middle Aged; Nutritional Status; Postmenopause; Reproducibility of Results; Vitamins; Young Adult | 2014 |
Quality-of-life outcomes with a disodium EDTA chelation regimen for coronary disease: results from the trial to assess chelation therapy randomized trial.
Topics: Adult; Aged; Calcium Chelating Agents; Chelation Therapy; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Edetic Acid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Quality of Life; Time Factors; Treatment Outcome | 2014 |
Design of the Trial to Assess Chelation Therapy (TACT).
Topics: Chelating Agents; Chelation Therapy; Complementary Therapies; Coronary Artery Disease; Dietary Supplements; Double-Blind Method; Edetic Acid; Female; Humans; Male; Middle Aged; Minerals; Research Design; Treatment Outcome; Vitamins | 2012 |
Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy.
Topics: Aged; Brachial Artery; Chelating Agents; Chelation Therapy; Coronary Artery Disease; Double-Blind Method; Edetic Acid; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Male; Middle Aged; Time Factors; Ultrasonography; Vasomotor System | 2003 |
15 other study(ies) available for edetic acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Platelet Volume Measurements-EDTA, Citrate, or Both?
Topics: Citrates; Citric Acid; Coronary Artery Disease; Edetic Acid; Humans; Inflammation; Platelet Count | 2018 |
[Alternative medicine sensation. Surprisingly effective: chelates and multivitamins in coronary heart disease].
Topics: Chelation Therapy; Complementary Therapies; Controlled Clinical Trials as Topic; Coronary Artery Disease; Drug Therapy, Combination; Edetic Acid; Germany; Humans; Risk Factors; Treatment Outcome; Vitamins | 2013 |
First impressions of cardiovascular calcification treatment in hemodialysis patients with a new dialysis fluid containing sodium thiosulphate (STS).
Topics: Biomarkers; Calcium Chelating Agents; Coronary Artery Disease; Edetic Acid; Hemodialysis Solutions; Humans; Pilot Projects; Renal Dialysis; Thiosulfates; Time Factors; Treatment Outcome; Vascular Calcification | 2014 |
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned.
Topics: Chelating Agents; Chelation Therapy; Clinical Trials, Phase III as Topic; Complementary Therapies; Coronary Artery Disease; Edetic Acid; Ethics, Research; Humans; Injections, Intravenous; National Institutes of Health (U.S.); Research Support as Topic; United States | 2008 |
Chelation therapy trials halted.
Topics: Autistic Disorder; Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Randomized Controlled Trials as Topic | 2008 |
Understanding coronary artery disease patients' decisions regarding the use of chelation therapy for coronary artery disease: descriptive decision modeling.
Topics: Aged; Chelating Agents; Coronary Artery Disease; Decision Making; Edetic Acid; Female; Humans; Male; Middle Aged; Patient Participation | 2012 |
Letter to the editor concerning article "Design of the Trial to Assess Chelation Therapy (TACT)".
Topics: Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Female; Humans; Male; Vitamins | 2012 |
Another test, another disappointment for chelation therapy.
Topics: Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Randomized Controlled Trials as Topic; Treatment Failure | 2003 |
The treatment of coronary artery disease with disodium EDTA. A reappraisal.
Topics: Coronary Artery Disease; Coronary Disease; Edetic Acid; Humans | 1963 |
WHOLE BLOOD VISCOSITY, HEMATOCRIT, AND SERUM LIPID LEVELS IN NORMAL SUBJECTS AND PATIENTS WITH CORONARY HEART DISEASE.
Topics: Blood Viscosity; Coronary Artery Disease; Coronary Disease; Edetic Acid; Erythrocyte Count; Hematocrit; Hemoglobinometry; Humans; Lipids | 1965 |
Coenzyme Q10 concentrations in coronary artery disease.
Topics: Adult; Cholesterol; Chromatography, High Pressure Liquid; Coenzymes; Coronary Artery Disease; Edetic Acid; Humans; Lipid Metabolism; Lipids; Membrane Potentials; Middle Aged; Mitochondria; Risk Factors; Ubiquinone | 2004 |
Iron chelating agents are not useful in treating atherosclerosis.
Topics: Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Iron; Peripheral Vascular Diseases | 1994 |
Effects of chelation with EDTA and vitamin B therapy on nitric oxide-related endothelial vasodilator function.
Topics: Acetylcholine; Analysis of Variance; Chelating Agents; Coronary Artery Disease; Drug Therapy, Combination; Edetic Acid; Female; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; Regional Blood Flow; Vasodilation; Vitamin B Complex | 1999 |
Chelation therapy.
Topics: Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Randomized Controlled Trials as Topic | 2002 |
[Arteriosclerosis and chelate therapy].
Topics: Aged; Arteriosclerosis; Brain Edema; Cerebral Infarction; Coronary Artery Disease; Edetic Acid; Female; Humans; Hypocalcemia; Ischemic Attack, Transient | 1986 |